Skip to content

Video to Promote HPV Vaccination

Educating Pre/Teens and Their Parents on the Importance of HPV Vaccination

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02196454
Enrollment
110
Registered
2014-07-22
Start date
2014-07-31
Completion date
2018-05-31
Last updated
2018-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acceptance Processes, Health Behavior, Human Papillomavirus, Social Acceptance, Vaccine Acceptance

Keywords

HPV vaccine, vaccination, immunization, video, health education, communication

Brief summary

The purpose of this research study is to determine if video-based education will increase HPV vaccination rates among 11 - 17 year olds.

Detailed description

Human Papillomavirus (HPV) is a common sexually transmitted infection that has the potential to cause cancer. The vaccine is recommended because it prevents the HPV infections that most commonly cause cancer. HPV vaccines offer the best protection to girls and boys who receive the complete, three-vaccine series and have time to develop an immune response before being exposed to HPV. However, vaccination rates are low compared to other vaccines for teens. Results from this study will help us learn why participants do or do not get the HPV vaccination and whether video-based education can help improve vaccination rates

Interventions

OTHEREducational Video with Male or Female Narrator

Participants will watch an educational video about the quadrivalent HPV vaccine (Gardasil) narrated by either a male or female.

Sponsors

Noble Medical, LLC
CollaboratorUNKNOWN
Children's Hospital of Philadelphia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
11 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Parent-child dyads in which the child is a male or female age 11 to 17 years who has not received the HPV vaccine

Exclusion criteria

* Parent-child dyads in which the child has received the HPV vaccine * Parent-child dyads in which the child is older than 18 at the time of enrollment * Non-English speakers

Design outcomes

Primary

MeasureTime frameDescription
HPV Vaccination Series Initiation90 daysNumber of HPV vaccine doses received among study participants
HPV Vaccine Series Initiation0 daysHPV Vaccine Receipt among study participants

Secondary

MeasureTime frameDescription
HPV Vaccine Series Initiation (depending on male versus female narrator)0 daysDifference in rate of HPV vaccine receipt between study participants who viewed a video narrated by a male versus a female

Other

MeasureTime frameDescription
HPV Vaccine Awareness0 daysReported reason for HPV vaccine receipt or deferral

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026